MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
3.590
+0.030 (0.84%)
May 18, 2026, 4:00 PM EDT - Market closed
MiMedx Group Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, MiMedx Group stock has a consensus rating of "Strong Buy" and an average price target of $6.50. The average 1-year stock price forecast is 81.06% higher than the current stock price, while the lowest is $5.00 (+39.28%) and the highest is $8.00 (+122.84%).
Price Target: $6.50 (+81.06%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for MiMedx Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 2 | 2 |
| Buy | 2 | 2 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +67.13% | Apr 30, 2026 |
| Citizens | Citizens | Buy Maintains $10 → $7 | Buy | Maintains | $10 → $7 | +94.99% | Apr 20, 2026 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +94.99% | Apr 17, 2026 |
| Citizens | Citizens | Buy Initiates $10 | Buy | Initiates | $10 | +178.55% | Feb 23, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $12 → $8 | Buy | Maintains | $12 → $8 | +122.84% | Feb 17, 2026 |
Financial Forecast
Revenue This Year
288.15M
from 418.63M
Decreased by -31.17%
Revenue Next Year
321.85M
from 288.15M
Increased by 11.70%
EPS This Year
-0.01
from 0.32
EPS Next Year
0.17
from -0.01
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 359.6M | 393.2M | |||
| Avg | 288.2M | 321.9M | |||
| Low | 254.8M | 284.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -14.1% | 36.5% | |||
| Avg | -31.2% | 11.7% | |||
| Low | -39.1% | -1.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.19 | 0.24 | |||
| Avg | -0.01 | 0.17 | |||
| Low | -0.13 | 0.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -40.9% | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.